Ryman Healthcare Limited logo

Request for information from NZ RegCo

Regulatory22 February 2023RYMHealthcare

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

23 February 2023


Request for information from NZ RegCo


Ryman Healthcare Limited is aware of recent media stories regarding its debt financing

arrangements. Yesterday evening, Ryman received a request from NZ RegCo for

information about its historical disclosures relating to its USPP facilities and about its

financial covenants.


Ryman will respond to the request and co-operate fully with NZ RegCo. Ryman also

confirms that it is in compliance with its continuous disclosure obligations.


Ryman recently announced a fully underwritten entitlement offer. That offer continues,

with settlement and allotment of new shares under the institutional offer taking place

this Friday. For further information, please refer to the investor presentation and

other offer materials released on 15 February 2023.













Important Notice

This communication is not for distribution or release in the United States. This communication does

not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the United States.

The entitlements and the New Shares have not been, and will not be, registered under the U.S.

Securities Act of 1933, as amended (U.S. Securities Act), or the securities laws of any state or other

jurisdiction of the United States, and may not be offered or sold, directly or indirectly, in the United

States or to any person acting for the account or benefit of any person in the United States, except in

transactions exempt from, or not subject to, registration under the U.S. Securities Act and applicable

securities laws of any state or other jurisdiction of the United States.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.